product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Microcephalin-1/BRIT1 (D38G5) Rabbit mAb
catalog :
4120
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D38G5
reactivity :
African green monkey, human, mouse, rat
application :
western blot, western blot knockout validation
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot knockout validation; African green monkey; 1:1000; loading ...; fig 1e
Ke Q, Li W, Lai X, Chen H, Huang L, Kang Z, et al. TALEN-based generation of a cynomolgus monkey disease model for human microcephaly. Cell Res. 2016;26:1048-61 pubmed publisher
Jia J, Abudu Y, Claude Taupin A, Gu Y, Kumar S, Choi S, et al. Galectins Control mTOR in Response to Endomembrane Damage. Mol Cell. 2018;70:120-135.e8 pubmed publisher
Yen W, Chaudhry A, Vaidyanathan B, Yewdell W, Pucella J, Sharma R, et al. BRCT-domain protein BRIT1 influences class switch recombination. Proc Natl Acad Sci U S A. 2017;: pubmed publisher
Ge C, Che L, Du C. The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex. PLoS ONE. 2015;10:e0144957 pubmed publisher
product information
SKU :
4120S
Product-Name :
Microcephalin-1/BRIT1 (D38G5) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
100
Host :
Rabbit
Target :
MCPH1
Primary-Protein :
MCPH1
Alt-Names :
BRCT-repeat inhibitor of TERT expression 1,BRIT1,FLJ12847,MCPH1,MCT,Microcephalin,microcephalin 1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.